These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The present status of ACTH therapy in multiple sclerosis. ALEXANDER L; CASS LJ Trans Am Neurol Assoc; 1961; 86():188-90. PubMed ID: 13860341 [No Abstract] [Full Text] [Related]
23. [On the problem of treatment of multiple sclerosis with Margulis - Shubladze vaccine]. ROGOVER AB Vestn Akad Med Nauk SSSR; 1961; 16(6)():49-53. PubMed ID: 14493385 [No Abstract] [Full Text] [Related]
24. Essential precautions in the treatment of new phenomena in multiple sclerosis. BRICKNER RM AMA Arch Neurol Psychiatry; 1953 Oct; 70(4):483-8. PubMed ID: 13091497 [No Abstract] [Full Text] [Related]
25. [Muscle relaxants in the therapy of multiple sclerosis]. WITTIG HH Med Welt; 1960 Apr; 16():857-9. PubMed ID: 13845503 [No Abstract] [Full Text] [Related]
26. [The Margoulis-Shubladze vaccine in the therapy of multiple sclerosis]. SCHERGNA E; FERRARIG G Psichiatr Neuropatol; 1961; 89():721-34. PubMed ID: 14498272 [No Abstract] [Full Text] [Related]
27. [Change in the reactivity of the body as a basis of pathogenetic therapy in multiple sclerosis]. LEONOVICH AL Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1453-7. PubMed ID: 13760977 [No Abstract] [Full Text] [Related]
28. [Remedial massage in multiple sclerosis]. SEDLACEK E Hippokrates; 1955 Dec; 26(24):749. PubMed ID: 13294739 [No Abstract] [Full Text] [Related]
29. [Cocarboxylase and multiple sclerosis]. REYMOND C; WILD C; BERAUD T; VANNOTTI A Schweiz Med Wochenschr; 1956 Mar; 86(13):328-31. PubMed ID: 13337186 [No Abstract] [Full Text] [Related]
30. Management of acute episodes in multiple sclerosis; discussion. BRICKNER RM AMA Arch Neurol Psychiatry; 1953 Jul; 70(1):111-2. PubMed ID: 13057410 [No Abstract] [Full Text] [Related]
31. [Trials with long-term treatment of multiple sclerosis with tolbutamide]. VOGT U Med Klin; 1962 Jun; 57():1016-7. PubMed ID: 13926484 [No Abstract] [Full Text] [Related]
32. Disseminated sclerosis. KREMER M Br Med J; 1958 Dec; 2(5110):1463-4. PubMed ID: 13596650 [No Abstract] [Full Text] [Related]
33. [Hormone status and the development of multiple sclerosis]. BIRKMAYER W; ISELSTOGER H; SEEMANN D Klin Med Osterr Z Wiss Prakt Med; 1955 Dec; 10(12):550-4. PubMed ID: 13286969 [No Abstract] [Full Text] [Related]
34. [Indications for therapeutic fasting in multiple sclerosis]. GEITHNER R Hippokrates; 1952 Dec; 23(23):675. PubMed ID: 13034157 [No Abstract] [Full Text] [Related]
35. [Cholinesterase, myelin and the treatment of multiple sclerosis]. ZINNITZ F; HAMMER O Z Gesamte Inn Med; 1959 Oct; 14():901-6. PubMed ID: 13847588 [No Abstract] [Full Text] [Related]
36. [New viewpoints in the treatment of multiple sclerosis]. WALCHER W Wien Arch Psychol Psychiatr Neurologie; 1955 Jun; 5(2):96-101. PubMed ID: 13274807 [No Abstract] [Full Text] [Related]
37. [Treatment of multiple sclerosis by novocain block of the sympathicus]. GOHRBANDT E Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1951 Nov; 270():295-303. PubMed ID: 14928675 [No Abstract] [Full Text] [Related]
38. Isoniazid in treatment of multiple sclerosis. BERLIN L; KURTZKE JF J Am Med Assoc; 1957 Jan; 163(3):172-4. PubMed ID: 13385127 [No Abstract] [Full Text] [Related]
39. Heparin potassium in the treatment of chronic multiple sclerosis. MASCHMEYER J; SHEARER R; LONSER E; SPINDLE DK Bull Los Angel Neuro Soc; 1961 Dec; 26():165-71. PubMed ID: 14470743 [No Abstract] [Full Text] [Related]
40. [Indirect irradiation of multiple sclerosis and other neurologic diseases]. BENTE D; SCHNEIDER W Strahlentherapie; 1951; 85(3):445-58. PubMed ID: 14922060 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]